Literature DB >> 12660217

Functional modulation of dendritic cells to suppress adaptive immune responses.

Andrea M Woltman1, Cees van Kooten.   

Abstract

In recent years, dendritic cells (DCs) have entered the center court of immune regulation. Dependent on their ontogeny, state of differentiation, and maturation and thereby a variable expression of membrane-bound and soluble molecules, DCs can induce immunostimulatory as well as immunoregulatory responses. This dual function has made them potential targets in vaccine development in cancer and infections as well as for the prevention and treatment of allograft rejection and autoimmune diseases. The present review is focused on the effect of immune-modulatory factors, such as cytokines and immunosuppressive drugs, and on the survival, differentiation, migration, and maturation of DC human subsets. A better understanding of DC immunobiology may lead to the development of specific therapies to prevent or dampen immune responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12660217     DOI: 10.1189/jlb.0902431

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  10 in total

1.  Proteasomal chymotrypsin-like peptidase activity is required for essential functions of human monocyte-derived dendritic cells.

Authors:  Cord Naujokat; Carsten Berges; Alexandra Höh; Hubert Wieczorek; Dominik Fuchs; Jörg Ovens; Marion Miltz; Mahmoud Sadeghi; Gerhard Opelz; Volker Daniel
Journal:  Immunology       Date:  2006-11-03       Impact factor: 7.397

2.  Impairment of circulating myeloid dendritic cells in immunosuppressed liver transplant recipients.

Authors:  B M Bosma; H J Metselaar; W M W Tra; S Mancham; E J Kuipers; H W Tilanus; J Kwekkeboom
Journal:  Clin Exp Immunol       Date:  2007-07-23       Impact factor: 4.330

3.  Studies of amplification, identification and resistant to maturation characteristics on immature dendritic cells derived from human peripheral blood in vitro.

Authors:  Haiming Xin; Wenxian Yang; Yan Jiang; Yitao Wang; Yalin Tong; Yizhi Peng
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-08-15       Impact factor: 2.416

4.  Human tolerogenic dendritic cells produce IL-35 in the absence of other IL-12 family members.

Authors:  Karen O Dixon; Sandra W van der Kooij; Dario A A Vignali; Cees van Kooten
Journal:  Eur J Immunol       Date:  2015-06       Impact factor: 5.532

Review 5.  Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity.

Authors:  Ryungsa Kim; Manabu Emi; Kazuaki Tanabe
Journal:  Immunology       Date:  2006-10       Impact factor: 7.397

6.  Evaluation of mast cells and burning sensation in various stages of Oral Submucous Fibrosis.

Authors:  Laliytha Bijai Kumar; Philips Mathew; Nirmal Madhavan; Sabin Siddique; Nandita Kshetrimayum; Kiran Iyer
Journal:  J Oral Biol Craniofac Res       Date:  2020-07-31

7.  Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells.

Authors:  Venky Ramakrishna; John P Vasilakos; Joseph D Tario; Marc A Berger; Paul K Wallace; Tibor Keler
Journal:  J Transl Med       Date:  2007-01-25       Impact factor: 5.531

8.  Induction of indoleamine 2, 3-dioxygenase in human dendritic cells by a cholera toxin B subunit-proinsulin vaccine.

Authors:  Jacques C Mbongue; Dequina A Nicholas; Kangling Zhang; Nan-Sun Kim; Brittany N Hamilton; Marco Larios; Guangyu Zhang; Kazuo Umezawa; Anthony F Firek; William H R Langridge
Journal:  PLoS One       Date:  2015-02-25       Impact factor: 3.240

9.  Inhibition of vascular endothelial growth factor by small interfering RNA upregulates differentiation, maturation and function of dendritic cells.

Authors:  Haiyan Wang; Luping Zhang; Shaoyan Zhang; Yannian Li
Journal:  Exp Ther Med       Date:  2014-11-11       Impact factor: 2.447

10.  Properdin and factor H production by human dendritic cells modulates their T-cell stimulatory capacity and is regulated by IFN-γ.

Authors:  Karen O Dixon; Joseph O'Flynn; Ngaisah Klar-Mohamad; Mohamed R Daha; Cees van Kooten
Journal:  Eur J Immunol       Date:  2017-03       Impact factor: 5.532

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.